Goldman Sachs sees room for investors to grow more bullish on US…
By David Randall NEW YORK (Reuters) - The sharp increase in investor equity allocations…
U.S. stocks may start to question economic resilience, says Morgan…
(Reuters) - The S&P 500 will likely struggle to make more headway after rallying…
US FDA puts Gilead Sciences blood cancer drug studies on hold
(Reuters) -Gilead Sciences said on Monday the U.S. health regulator placed a clinical…
How airlines cope with price surge during disasters
By Allison Lampert and Doyinsola Oladipo (Reuters) -Canadians vented their frustration…
Marketmind: Bonds burn on as China rate cut underwhelms
A look at the day ahead in U.S. and global markets from Mike Dolan There's been…
China’s fiscal revenue slows as economy struggles
BEIJING (Reuters) -China's fiscal revenue rose 11.5% in the first seven months of…
Less cash, fewer bears could leave U.S. stocks vulnerable
By David Randall NEW YORK (Reuters) -Several indicators that pointed to upside for U.S.…
North Korean hackers target U.S.-South Korea military drills, police…
By Ju-min Park SEOUL (Reuters) - Suspected North Korean hackers have targeted a joint…
Elon Musk says X will strip ability to block accounts
(Reuters) - Social media company X, formerly known as Twitter, will remove a protective…
US FDA approves Regeneron’s ultra-rare blood disease drug
By Pratik Jain (Reuters) -Regeneron Pharmaceuticals said on Friday the U.S. health…